One emerging industry could be the next investment opportunity
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Global biotech company Zoono Group Limited (ASX:ZNO) Founder and CEO Paul Hyslop is an expert on long lasting antimicrobial protection and outlines the industry opportunity to The Capital Network’s Executive Director Lelde Smits. Long lasting antimicrobial protection is an emerging industry and Mr Hyslop outlines why it presents a compelling investment opportunity, why global product developers have not embraced it, and where the future lies for the industry.
Lelde Smits: Hello, I’m Lelde Smits for The Capital Network, and joining me is the founder, CEO and major shareholder of New Zealand-based, ASX listed Zoono Group (ASX:ZNO), Paul Hyslop. Paul, welcome.
Paul Hyslop: Hi, Lelde. Thank you. Nice to be here.
Lelde Smits: Paul is an expert on long lasting antimicrobial solutions and Paul I’d like to start by asking you what exactly are they and why are we only now just starting to hear about long lasting antimicrobial solutions?
Paul Hyslop: A long lasting antimicrobial solution is a product that is applied to surfaces, skin, fabrics, and it will kill all the bacteria on the surfaces applied to, and then it will afford protection for extended periods of time.
Lelde Smits: Where has this technology originated from and how is it now being developed?
Paul Hyslop: It actually originated a long time ago. The active ingredient was originally developed way, way back. But it wasn’t really used. I found the active ingredient about ten years ago, and I saw a lot of different applications for it. It was quite an unstable active ingredient, quite hard to work with, and we’ve evolved the active ingredient to a commercial product.
Lelde Smits: When we look at the global market for long lasting antimicrobial solutions, why aren’t we seeing global players really implement more of this technology into the products that we see on supermarket shelves?
Paul Hyslop: Global players in the pharmaceutical and chemical industry, their business model is to sell millions of litres of product over and over again that are applied many times a day, many times a week, many times a year. And those millions of litres, they end up in the waterways, they end up in the ocean, they end up in the ground. They often do not break down in the environment, but for them to go into a long lasting antimicrobial solution is totally against their philosophy.
Lelde Smits: When you look at the outlook for this sort of technology, that you have described as disruptive to the industry, where do you see the biggest opportunities being presented in terms of geographies and also sectors that are applying long lasting antimicrobial solutions?
Paul Hyslop: It can be used globally of course and the sectors are almost endless, from cruise liners to aircrafts, to hospitals, to age care facilities, childcare facilities, food manufacturing facilities, farms, poultry farms for instance, pig farms. It’s almost endless, really, it goes on and on, households, universities, schools.
Lelde Smits: That certainly is quite a list. Thank you so much for outlining all of the opportunities for this emerging sector.
Paul Hyslop: Great, thank you.
General Information Only
This material has been prepared by Jason Price. Jason Price is an authorised representative (AR 000296877) of 62 Consulting Pty Limited (ABN 88 664 809 303) (AFSL 548573) (62C), and a Director of S3 Consortium Pty Ltd (trading as StocksDigital).
This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by 62C, Jason Price, StocksDigital, any of their related body corporates or any other person. To the maximum extent possible, 62C, Jason Price, StocksDigital, their related body corporates or any other person do not accept any liability for any statement in this material.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
